Inovio Pharmaceuticals Inc
F:GBM
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Inovio Pharmaceuticals Inc
F:GBM
|
US |
|
Kuros Biosciences AG
F:YTSN
|
CH |
|
MorphoSys AG
NASDAQ:MOR
|
DE |
|
Medexus Pharmaceuticals Inc
F:P731
|
CA |
|
C
|
Clean Power Hydrogen PLC
LSE:CPH2
|
UK |
|
DiaMedica Therapeutics Inc
NASDAQ:DMAC
|
US |
|
P
|
PG&E Corp
SWB:PCG
|
US |
|
Avon Protection PLC
F:1OK
|
UK |
|
Amcor PLC
OTC:AMCCF
|
UK |
|
Culp Inc
NYSE:CULP
|
US |
|
L
|
Lime Technologies AB (publ)
F:LTX
|
SE |
|
Pet Valu Holdings Ltd
TSX:PET
|
CA |
|
FIRST BANK (Hamilton)
F:6UT
|
US |
|
M
|
Mixi Inc
F:MXN
|
JP |
|
I
|
International Game Technology PLC
SWB:7IG
|
UK |
|
T
|
Tencent Music Entertainment Group
F:63TA
|
CN |
|
M
|
MorphoSys AG
XBER:MOR
|
DE |
|
T
|
Takeda Pharmaceutical Co Ltd
DUS:TKD
|
JP |
|
LS Electric Co Ltd
KRX:010120
|
KR |
|
Cenergy Holdings SA
F:9CN
|
BE |
Bankruptcy Probability
Inovio Pharmaceuticals Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Inovio Pharmaceuticals Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Inovio Pharmaceuticals Inc
NASDAQ:INO
|
93.8m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
383.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
182.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
160.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
108.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
65.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
43B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
|
39B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Inovio Pharmaceuticals Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Inovio Pharmaceuticals Inc has no debt.
You can find a full breakdown on its Balance Sheet.
